+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
HEMORGANIC HEMORGANIC

Hemo Organic Share Price

₹21.88 +1.04 (4.99%)
169.46% Gain from 52W Low

28 Sep, 2026 4:01 PM (IST)

Hemo Organic live price: ₹21.88. It opened at ₹22 vs previous close ₹21; intraday high/low: ₹22/₹22. The 50 & 200 DMA stand at ₹18.30/₹14.70.

Hemo Organic Performance

  • Today's Low
  • ₹22
  • Today's High
  • ₹22
  • 52 Week Low
  • ₹8
  • 52 Week High
  • ₹24
  • Open Price₹22
  • Previous Close₹21
  • Volume4,104
  • 50 DMA₹18.30
  • 100 DMA₹16.50
  • 200 DMA₹14.70

Hemo Organic Chart

Investment Returns

  • Over 1 Month + 15.71%
  • Over 3 Month + 3.65%
  • Over 6 Month + 87.01%
  • Over 1 Year + 130.32%

Smart Investing Starts Here Start SIP with Hemo Organic for Steady Growth!

Invest Now

Hemo Organic Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -19.6
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 15
  • P/B Ratio
  • 4.3
  • Average True Range
  • 1.2
  • EPS
  • -1.1
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.8
  • RSI
  • 58.74
  • MFI
  • 44.05

Latest Stock News Updates

Hemo Organic Ltd - 524590 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday, 3Rd October, 2026.

Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/10/2026 ,inter alia, to consider and approve 1. To consider and approve the proposal for raising funds, in one or more tranches by way of issue of Equity Shares and/or Convertible Securities, including Convertible Warrants, for cash or on consideration other than cash, including by way of share swap, through preferential allotment, private placement, qualified institutions placement ('QIP'), rights issue, further public issue or any other permissible mode or combination thereof subject to such statutory /regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and ancillary actions for such fund raising. 2. Any other agenda matter to be discussed with the permission of Chairman of the Board Meeting.

Hemo Organic Ltd - 524590 - Closure of Trading Window

Intimation of Closure of Trading Window

Hemo Organic Ltd - 524590 - Announcement under Regulation 30 (LODR)-Allotment

Intimation under Regulation 30 of SEBI(LODR) Regulations, 2015 for Allotment of fully paid-up equity shares purusant to conversion of warrants issued through preferential basis.

Hemo Organic Financials

Hemo Organic Technicals

EMA & SMA

Current Price
₹21.88
+ 1.04 (4.99%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹20.50
  • 50 Day
  • ₹18.30
  • 100 Day
  • ₹16.50
  • 200 Day
  • ₹14.70

Resistance and Support

21.89 Pivot Speed
  • R3 21.90
  • R2 21.90
  • R1 21.90
  • S1 21.90
  • S2 21.90
  • S3 21.80

Hemo Organic Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-03 Preferential issue of shares
2026-07-15 Quarterly Results
2026-05-29 Audited Results
2026-02-13 Quarterly Results
2025-11-14 Quarterly Results & Preferential issue Inter-alia, to consider 1. Raising funds through the issuance of one or more instruments, including equity shares, warrants convertible into equity shares or other securities or any other permissible mode. 2. Other business matters.

Hemo Organic Shareholding Pattern

83.16%
16.85%
0%

Hemo Organic FAQs

Hemo Organic share price is ₹21 As on 01 October, 2026 | 09:17

The Market Cap of Hemo Organic is ₹15 Cr As on 01 October, 2026 | 09:17

The P/E ratio of Hemo Organic is -19.6 As on 01 October, 2026 | 09:17

The PB ratio of Hemo Organic is 4.3 As on 01 October, 2026 | 09:17

The 52 week High & Low of Hemo Organic is ₹24.4/₹8.1 respectively As on 01 October, 2026 | 09:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23